日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer

MTA 协同 PRMT5 抑制剂 BMS-986504 与 KRAS 抑制剂联合使用是治疗 MTAP 缺失 KRAS 突变型胰腺癌的有效策略

Drizyte-Miller, Kristina; Engstrom, Lars D; Klomp, Jeffrey A; Stalnecker, Clint A; Stamey, Addison G; Taylor, Khalilah E; Roach, Mallory K; Robb, Ryan; Waters, Laura M; Calinisan, Andrew; Degan, Seamus; Chang, Wen-Hsuan; Helu, Xousaen M; Nguyen, David; Baldelli, Elisa; Pierobon, Mariaelena; Petricoin, Emanuel F; Briere, David M; Hallin, Jill; Christensen, James G; Bryant, Kirsten L; Cox, Adrienne D; Olson, Peter; Der, Channing J

Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.

KRYSTAL-1 试验中,Adagrasib 治疗非小细胞肺癌患者的共突变和转录特征的影响

Negrao Marcelo V, Paula Alvaro G, Molkentine David, Hover Laura, Nilsson Monique, Vokes Natalie, Engstrom Lars, Calinisan Andrew, Briere David M, Waters Laura, Hallin Jill, Diao Lixia, Altan Mehmet, Blumenschein George R, Skoulidis Ferdinandos, Wang Jing, Kopetz Scott E, Hong David S, Gibbons Don L, Olson Peter, Christensen James G, Heymach John V

Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein

发现能选择性抑制H1047R PI3Kα突变蛋白的吡啶并嘧啶酮类化合物

Ketcham, John M; Harwood, Stephen J; Aranda, Ruth; Aloiau, Athenea N; Bobek, Briana M; Briere, David M; Burns, Aaron C; Caddell Haatveit, Kersti; Calinisan, Andrew; Clarine, Jeffery; Elliott, Adam; Engstrom, Lars D; Gunn, Robin J; Ivetac, Anthony; Jones, Benjamin; Kuehler, Jon; Lawson, J David; Nguyen, Natalie; Parker, Cody; Pearson, Kelly E; Rahbaek, Lisa; Saechao, Barbara; Wang, Xiaolun; Waters, Anna; Waters, Laura; Watkins, Ashlee H; Olson, Peter; Smith, Christopher R; Christensen, James G; Marx, Matthew A